Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Inovio Pharmaceuticals Will Fall Once Coronavirus Fears Fade

INO stock has moved higher based on Inovio's hunt for a coronavirus vaccine. But this race also makes the pharmaceutical firm a one-dimensional investment.

Starbucks Stock Isn’t Among the Best Choices in the Current Environment

Investors who only plan to hold SBUX stock for more than a few weeks but less than a year (when strong fears about the coronavirus are likely to be largely gone) should avoid the coffee retailer's shares.

Oil Wars and Bear Markets Are Too Much for Nio Stock

Even under bull market conditions, Nio stock was a risky opportunity. But in a bear market that is especially tough on automakers, Nio is too treacherous.

Why Fear is Temporarily Driving Sturm Ruger Stock to Higher Highs

The coronavirus from China panic won’t last forever, and neither will recent higher highs in gun stocks like Ruger stock.

It’s Time for Investors to Run Far Away From iBio Stock

Don’t let me talk you out of iBio stock, but a bit of skepticism is required given the massive hype behind this bio-pharmaceutical COVID-19 play.

It Might Be Too Early to Consider Buying Apple Stock

Coronavirus will impact Apple stock throughout 2020. But 5G phones and wearables will enable the company to grow next year.

The Coronavirus Is the Latest Obstacle for CGC Stock

The cannabis industry faced significant challenges before the coronavirus erupted. But with the pandemic bringing everything to a halt, CGC stock is simply not worth the risk.

Can Restructuring Salvage CHK Stock?

The price war between Saudi Arabia and Russia is enough to scare a giant oil firm, let alone an embattled one like Chesapeake Energy. Therefore, unless a miracle occurs, CHK stock is a sell.

iBio Stock Isn’t the Coronavirus Play Investors Want It to Be

Underscoring the volatility associated with companies purporting to be on the cusps of cures or treatments for international pandemics, IBIO has more than quadrupled just this month, but the stock resides 63.53% below the 52-week high notched in early March.

Stop Chasing Coronavirus Plays Like Moderna Stock

Stocks like MRNA stock have soared on hopes they will benefit from the coronavirus pandemic. But history shows few, if any, actually will.

Without Boeing, General Electric Stock Is Dead in the Water

With the airline industry taking a cataclysmic hit, there’s simply no way that the recovery narrative for GE stock is feasible.

Virgin Galactic Stock: Where Speculation Meets the Final Frontier

Virgin Galactic offers a lot of potential, but the stock is battered and still expensive. Interested investors should avoid it for now.

LYFT Stock Faces More Than a Bad Review from the Coronavirus

Ride sharing and the prominence of individual names like LYFT stock was easily among the most promising investments. Now, the underlying company is in a fight for its life.

Intel Will Survive but INTC Stock Could Fall Much Further

Intel will survive just fine given its massive FCF, but INTC stock could fall much further. Even though FCF covers the dividend, INTC stock could drop over 35% to its highest dividend yield.

It’s Time to Abandon Ship in RCL Stock

The coronavirus pandemic has been a cruel headwind, particularly for cruise liners. With imploding demand globally, RCL stock is a name to avoid.

Will Candor Be Enough to Save JBLU Stock?

JetBlue's transparency amid the crisis is admirable. However, transparency alone won't bring back sentiment for JBLU stock.

Why Beyond Meat Stock Is Struggling to Return to Glory

Beyond Meat stock is no longer sizzling hot, especially in the face of the coronavirus. Here are several reasons why the stock is risky.

Aurora Lacks Leadership, Funding and Credibility

With the many risky decisions that management took that obviously didn’t pan out, ACB stock looks like dead money.

Chevron Stock Is in the Fight of Its Life

If you’re thinking about betting on Chevron’s market weakness, just wait a bit. Wall Street is probably in denial and not fully recognizing the turmoil facing Chevron stock and the oil industry.